Andrew Whitfield-Cook

andrew_whitfieldcook's picture
Andrew Whitfield-Cook
Andrew is a registered nurse of 32 years, with more than 20 years experience in the natural medicine industry. As a Senior Educator at with one of Australia's leading nutraceutical companies, he has the responsibility of explaining complex biochemical processes using simple analogies to help individuals understand how they apply to wellbeing. He delights in researching biochemistry, pathophysiology as well as nutritional and herbal medicines. His favourite patient interests include: gastroenterology, immunology and oncology. He has lectured to nutritionists, naturopaths, nurses, dietitians, pharmacists and doctors Australia-wide.
Aug 05, 2016

Research shows that sea buckthorn is a safe and effective option for post-menopausal vaginal atrophy.

Jul 08, 2016

You may be blissfully unaware of the issue of herbal adulteration in the natural medicine industry. In this article, Andrew puts this issue under the microscope. 

Mar 08, 2016

With emerging evidence that vitamin D may mediate immunomodulatory effects in patients with IBD, this study aimed to assess a specific supplementation regimen of vitamin D to increase serum 25(OH)D to 100-125nmol/L, and to evaluate change in disease activity.

Feb 26, 2016

Research shows we emit a microbial cloud into our surroundings that is as unique as a fingerprint.

Jan 22, 2016

Dysbiotic gut bacteria have an impact on paracetamol and other drugs' safety lending credence to the clinical relevance of conducting Liver Detoxification Profiles in patients.

Nov 27, 2015

Taking a look at research that acutely highlights the shortcomings of taking a reductionist view to the application of single strain or species probiotic therapy as an exclusive approach in clinical practice.

Nov 04, 2015

Zinc carnosine has been quoted as being three times more effective than the singular ingredients, and has greater ulcer healing effects than cimetidine, a first generation anti-ulcer drug with significant drug-drug interactions.

Oct 16, 2015

Results from a new study suggest microbial diversity of the oral and intestinal mucosa in patients with acute myelogenous leukemia (AML) has a significant impact on the risk for infectious complication in the first three months of induction chemotherapy.